Suzanne C. Cannegieter

MD, PhD, prof
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Leiden, Zuid-Holland, Netherlands

Presentation(s):

• PUB 01.2 - How to get involved with JTH as an early career author, reviewer, and associate editor

  Saturday, June 22, 2024
  11:15 – 11:30 ICT

• OC 16.3 - Distinct proteomic profiles after remission of Cushing syndrome, but coagulation-related proteins remained abnormal

  Sunday, June 23, 2024
  10:00 – 10:15 ICT

• PB0281 - Baseline coagulation factor levels determine desmopressin response in bleeding disorders: a systematic review and meta-analysis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0002 - Low prevalence of cardiovascular risk factors in persons aged fifty years or younger with venous thromboembolism

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0420 - Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard ‘one size fits all’ approach in patients undergoing Total hIp or total kNee replaCement.

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0003 - Time trends in vitamin K antagonist (VKA) treatment in the Netherlands in an era of transition to DOACs and lowering of VKA target intensity

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• OC 23.1 - Clinical outcomes and use of antithrombotic therapy in patients with peripheral artery disease with incident venous thromboembolism: a Dutch nationwide cohort study

  Sunday, June 23, 2024
  14:45 – 15:00 ICT

• OC 23.3 - Concurrent use of novel antidiabetic drugs and risks of adverse events among atrial fibrillation patients receiving chronic anticoagulation

  Sunday, June 23, 2024
  15:15 – 15:30 ICT

• OC 23.4 - Long-term maternal risk of cardiovascular diseases after pregnancy in the era of increasing aspirin use for preventing preeclampsia: A nationwide population-based study in the Netherlands

  Sunday, June 23, 2024
  15:30 – 15:45 ICT

• OC 31.5 - Time trends (2013-2019) in antithrombotic therapy prescriptions and thromboembolic complications during the postpartum period in the Netherlands: a nationwide study

  Monday, June 24, 2024
  10:30 – 10:45 ICT

• PB0943 - Clinical characteristics and mortality of older patients diagnosed with acute pulmonary embolism on the emergency department, compared to other older patients in the emergency department

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0918 - Outcomes of chronic thromboembolic pulmonary hypertension with or without prior venous thromboembolism

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0929 - Treatment of acute pulmonary embolism in older patients: focus on deviations from guideline recommendation for home treatment and reperfusion treatment

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 53.4 - Quantitative targeted proteomics identifies novel biomarkers for prediction of major bleeding during anticoagulation: a prospective case-cohort study.

  Tuesday, June 25, 2024
  10:15 – 10:30 ICT

• OC 54.3 - Body fat distribution and coagulation profiles: exploring the link between obesity and venous thromboembolism

  Tuesday, June 25, 2024
  10:00 – 10:15 ICT

• PB0983 - Frequency of discontinuation of vitamin K antagonists and occurrence of bleeding and thromboembolic events in long-term users with a limited life expectancy

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1408 - Incidence and determinants of venous thromboembolic and bleeding complications in patients with hepatocellular carcinoma – the Tityos study

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1181 - Plasma proteomic profiles of patients during anticoagulant treatment with vitamin K antagonists.

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1412 - Thromboembolic and bleeding events and use of antithrombotic therapy in patients with advanced cancer: a Dutch nationwide cohort study from the SERENITY consortium

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB1373 - Time-dependent associations between COVID-19 disease severity, coagulation proteins, venous thromboembolism and all-cause mortality

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• PB0981 - Vitamin K antagonist treatment quality in the last year of life: a multicentre observational cohort

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 62.4 - Hormonal contraceptive use after a first venous thromboembolism and the risk of recurrence in premenopausal women

  Tuesday, June 25, 2024
  15:30 – 15:45 ICT

• OC 64.5 - Antithrombotic therapy and its discontinuation in patients with cancer during their last phase of life: a primary care cohort study from the SERENITY consortium

  Tuesday, June 25, 2024
  15:45 – 16:00 ICT